Financing Your Business 
Thursday, October 25, 2007
6 to 8 pm
Reception to follow

Registration for this event is now closed

Sidney E. Frank Hall for Life Sciences
185 Meeting Street (Between Thayer & Brown Streets)
Brown University, Providence, Rhode Island

Of all the challenges an entrepreneur faces, one of the most important is financing.  Knowing the options at each fundraising stage and choosing the right investment partner for your business are essential to your success.  In this Forum, you’ll hear about the regional funding landscape, along with international perspectives and opportunities, as speakers from world-class firms acquaint you with trends and prospects in the bio-tech and info-tech venture capital worlds. 

Hosted by: David Josephs, Principal, Barlow Josephs & Holmes
Moderated by: James Hahn, Partner, Partridge Snow & Hahn

Presenters
Garrett Hunter, President, Business Development Company of Rhode Island and Founder, Cherrystone Angel Group
BDCRI is a non-bank lender which provides debt and equity financing to help promising, but often undercapitalized, companies grow and expand employment.  Their portfolio includes manufacturers and distributors, as well as software, medical technology and other high-tech businesses.  Cherrystone Angel Group, based in Providence, offers start-up investment funds to local, emerging companies that need seed capital, as well as guidance developing strategic partnerships, recruiting their management team and/or refining product strategy.     

Gus Lawlor, Managing Director, HealthCare Ventures, LLC
HealthCare Ventures is a leading venture capital firm specializing in life science industry investing.  Their focus is on early stage companies capable of developing novel products that will change the practice of medicine and improve pharmaceutical product manufacturing.  Well-known for developing excellent management teams, HealthCare Ventures works closely with its portfolio companies to set direction, build value, manage financing and secure liquidity.  Their areas of investment interest include: target-focused cancer, infectious disease, cardiovascular disease, central nervous system disorders, immunomodulation and immunotherapy, novel manufacturing technologies, and novel lab scale instruments and reagents.
View Gus Lawlor's Presentation

Jon Karlen, Principal, IDG Ventures Boston
IDG Ventures is a global network of venture capital funds with approximately $1.4 billion under management and a portfolio of over 220 companies built over the last 15 years.  The IDG Ventures network is comprised of five independent partnerships managing funds in North America and Asia.  Each partnership makes investments on behalf of its limited partners, including International Data Group, the world’s largest IT media company. With $280 million under management, IDG Boston is focused on investing in early stage information and healthcare technology companies.
View Jon Karlen's Presentation